European Companies Search Engine
Orion Oyj, Espoo, Finland
Watch
If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.
Dossier
The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .
Add to dossier (if available):
Name
Orion Oyj
Chemion
Lääkefarmos
Medipolar
Orion Corporation
Orion Pharma
Pharmacal
Suomen Rohdos
Register
Bis
PRH 1999212-6
Address
Corporate purpose
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories, as well as consumers with pets. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) product portfolio for the treatment of asthma and COPD; and a research collaboration and license agreement with Alligator Bioscience AB (publ) to discover and develop new bispecific antibody cancer therapeutics. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.
Additional info
21.20.0
Manufacture of pharmaceutical preparations
History
Network
Loading network
Publications
17 Jun 2024
17 Jun 2024
Year 2023
in
Euipods
Year 2022
in
Euipods
Year 2021
in
Euipods
Year 2020
in
Euipods
Year 2019
in
Euipods
4 Oct 2019
6 Sept 2018
28 Aug 2017
in
Hor
Year 2015
in
Euipotm
Year 2014
in
Euipotm
Year 2009
in
Euipotm
24 Apr 2007
5 Feb 2007
14 Nov 2006
8 Nov 2006
31 Oct 2006
Mentions
9 Aug 2023
via
ORION Pharma GmbH
9 Aug 2023
via
ORION Pharma GmbH
The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.
The visualizations for "Orion Oyj, Espoo, Finland"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
